Advertisement

Topics

Dr Reddy's saw API revenues slide in FY Q1 2018

13:04 EDT 2 Aug 2017 | in-PharmaTechnologis

Dr Reddy's says efforts to fix plant problems flagged by US FDA impacted its active pharmaceutical ingredient (API) business in the first quarter of fiscal 2018.

Original Article: Dr Reddy's saw API revenues slide in FY Q1 2018

NEXT ARTICLE

More From BioPortfolio on "Dr Reddy's saw API revenues slide in FY Q1 2018"

Quick Search
Advertisement